Sodium Hydroxide → HCID 89500600, compound
Reaction equation
[O:1]=[C:2]1[CH2:7][CH2:6][CH2:5][CH2:4][N:3]1[C:8]1[CH:13]=[CH:12][CH:11]=[CH:10][C:9]=1[CH2:14][CH2:15][N:16]1[CH2:21][CH2:20][CH2:19][CH:18]([C:22]2[CH:31]=[CH:30][CH:29]=[CH:28][C:23]=2[C:24]([O:26]C)=[O:25])[CH2:17]1.[OH-].[Na+]>CO>[O:1]=[C:2]1[CH2:7][CH2:6][CH2:5][CH2:4][N:3]1[C:8]1[CH:13]=[CH:12][CH:11]=[CH:10][C:9]=1[CH2:14][CH2:15][N:16]1[CH2:21][CH2:20][CH2:19][CH:18]([C:22]2[CH:31]=[CH:30][CH:29]=[CH:28][C:23]=2[C:24]([OH:26])=[O:25])[CH2:17]1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 80 °C
Procedure
Methyl 2-(1-{2-[2-(2-oxopiperidin-1-yl)phenyl]ethyl}piperidin-3-yl)benzoate a6-1 (0.35 g, 0.84 mmol, 1 eq) is dissolved in methanol (5 ml). NaOH 5N (0.84 ml, 4.20 mmol, 5 eq) is added and the mixture is heated at 80° C. for 16 h. The reaction mixture is concentrated under reduced pressure and the residue obtained is taken up in MeOH, filtered, and evaporated to afford 0.34 g of crude 2-(1-{2-[2-(2-oxopiperidin-1-yl)phenyl]ethyl}piperidin-3-yl)benzoic acid a6-5 which is used in the next step without further purification.
Workup
- concentrationThe reaction mixture is concentrated under reduced pressure
- customthe residue obtained
- filtrationfiltered
- customevaporated
Sources & evidence
- ORD record
- ord-6b0d0960534143e48ed1e7fba0424a10
- Source dataset
- uspto-grants-2015_06
- Patent number
- US09067930B2
Reaction notes
Loading…